Top news of the week: 17.03.2023.
Pfizer Invests $43 Billion to Battle Cancer
Pfizer Inc. (NYSE: PFE) and Seagen Inc. (Nasdaq: SGEN) today announced that they have entered into a definitive merger agreement under which Pfizer will acquire Seagen, a global ...
Pfizer Invests $43 Billion to Battle Cancer
Pfizer to acquire Seagen for $229 per Seagen share in cash, for a total enterprise value of approximately $43 billionProposed combination enhances Pfizer’s position as a leading company in ...
Newron Announces 2022 Financial Results and Provides Outlook For 2023
Ad hoc announcement pursuant to Art. 53 LRMILAN--(BUSINESS WIRE)--Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of ...
Introduction to Synthetic Biology
Special Event 05/23/2023 New Attendee Reception 6:00 pm - 05/23/2023 Registration Hours 7:00 am - 6:00 pm 05/23/2023 Breakfast 10th Street 7:15 am - 8:15 am 05/23/2023 Welcome …
Switch Therapeutics Launches with $52 Million to Advance First-of-its-Kind RNAi Technology
-- Novel approach to gene knockdown uses proprietary CASi (Conditionally Activated siRNA) molecules optimized to “switch” on, activating siRNA therapeutics only in selected cells ---- CASi ...
Catamaran Bio selects OmniaBio as partner to develop and manufacture allogeneic CAR-NK cell therapies
BOSTON & TORONTO--(BUSINESS WIRE)--Catamaran Bio Inc., a biotechnology company developing off-the-shelf NK cell therapies to treat cancer, and OmniaBio Inc., a contract development and ...
Orum Therapeutics Announces Three Presentations at AACR 2023
BOSTON & DAEJEON, South Korea--(BUSINESS WIRE)--#ADC--Orum Therapeutics, Inc. (“Orum”), a private biotechnology company pioneering the development of tumor-directed targeted protein ...
5 reasons why collaboration is important in research
Learn more about the importance of collaboration in research and its many benefits from experts in the biotech industry.